Rapamycin (Sirolimus) Cost in South Carolina: 2026 Pricing, Insurance, and Savings Guide

How Much Does Rapamycin (Sirolimus) Cost in South Carolina in 2026?
At a glance
- Average SC retail cash price (generic sirolimus) / $80 per month
- Compounded sirolimus via 503A pharmacy / approximately $120 per month
- Pfizer Rapamune manufacturer list price / $600 per month
- South Carolina Medicaid coverage for off-label longevity / not covered
- Telehealth prescribing in South Carolina / permitted
- Compounded sirolimus availability / legal via licensed 503A pharmacies
- Common off-label longevity dose / 3 to 6 mg once weekly
- Transplant dosing schedule / daily oral tablet
- Manufacturer savings card / available for eligible commercially insured patients
- Prescription status / prescription only
South Carolina Retail Pricing for Sirolimus in 2026
The average cash-pay price for generic sirolimus at South Carolina retail pharmacies sits near $80 per month as of mid-2026. That figure reflects 1 mg tablets dispensed at a quantity of 30, the standard transplant supply. Patients filling a once-weekly off-label prescription (four to five tablets per month) may pay less depending on the dose prescribed.
Branded Rapamune from Pfizer lists at roughly $600 per month, a number that rarely represents what anyone actually pays out of pocket. The gap between list price and generic price exists because sirolimus lost patent exclusivity years ago, and multiple generic manufacturers (Greenstone, Biocon, Zydus) now compete on price. South Carolina has no state-specific drug pricing regulations that differ materially from the federal framework, so generic competition is the primary force keeping costs at the $80 level.
Pharmacy-to-pharmacy variation across the state can range from roughly $55 to $110 for the same generic prescription. Pharmacies in larger metro areas like Charleston, Columbia, and Greenville tend to price lower due to higher volume and competition. Rural pharmacies in the Upstate or Pee Dee region may sit at the higher end.
Compounded Sirolimus: Legality and Pricing in South Carolina
Compounded sirolimus is legal in South Carolina when dispensed by a pharmacy operating under a valid 503A license from the FDA. These pharmacies prepare patient-specific prescriptions based on a valid prescriber-patient relationship. The typical price for compounded sirolimus in South Carolina is approximately $120 per month.
Why would someone pay $120 for a compounded version when generic tablets cost $80? Two reasons. First, compounding pharmacies can prepare custom dosage forms (topical rapamycin cream for skin aging, low-dose capsules calibrated to weekly longevity protocols) that commercial manufacturers do not offer. Second, some clinicians prescribing off-label longevity protocols prefer specific dose increments (1.5 mg, 2 mg, 5 mg weekly) that do not align neatly with the available 0.5 mg, 1 mg, and 2 mg commercial tablets.
South Carolina does not impose additional state-level restrictions on 503A compounding beyond the federal requirements. The state Board of Pharmacy regulates in-state compounding pharmacies, while out-of-state 503A pharmacies shipping into South Carolina must hold a nonresident pharmacy license. Patients receiving compounded sirolimus via mail order from an out-of-state 503A pharmacy should confirm the pharmacy holds this license.
503B outsourcing facilities, which can compound without individual prescriptions, are a separate category. These are FDA-registered and inspected, and they may supply physician offices directly. Some longevity clinics in South Carolina source bulk compounded sirolimus from 503B facilities for in-office dispensing.
South Carolina Medicaid and Sirolimus Coverage
South Carolina Medicaid does not cover sirolimus for off-label longevity indications. The drug is listed on the state's preferred drug list only for its FDA-approved indications: prevention of organ rejection in renal transplant recipients aged 13 and older, and treatment of lymphangioleiomyomatosis (LAM).
For transplant patients enrolled in SC Medicaid, sirolimus requires prior authorization. The prescriber must document the transplant type, date, and concomitant immunosuppressive regimen. Approval is typically granted for 12-month periods with renewal documentation. The South Carolina Department of Health and Human Services (SCDHHS) publishes its preferred drug list with quarterly updates.
For patients seeking rapamycin for geroprotective or anti-aging purposes, Medicaid will deny the claim. This is consistent with nearly every state Medicaid program in 2026. No state currently covers sirolimus for longevity. Self-pay or commercial insurance with an off-label friendly formulary remain the only paths.
Commercial Insurance Coverage in South Carolina
Commercial insurance coverage for sirolimus in South Carolina depends on the plan, the indication, and whether the prescriber submits supporting documentation for off-label use. For transplant patients, most major plans (BlueCross BlueShield of South Carolina, Absolute Total Care, Molina, Select Health of South Carolina) cover generic sirolimus with a tier 2 or tier 3 copay, usually $20 to $50 per month after prior authorization.
Off-label longevity prescriptions face a steeper climb. Most commercial formularies do not list anti-aging as a covered indication. Some patients have reported success getting claims approved when the prescriber frames the prescription around a covered comorbidity. For instance, a patient with documented mTOR pathway overactivation, metabolic syndrome, or a specific autoimmune condition may find a path to coverage.
A 2023 Endocrine Society clinical practice guideline noted that mTOR inhibitors like sirolimus show promise in metabolic regulation, though the society stopped short of recommending routine off-label prescribing. Citing such guidelines in a prior authorization letter may strengthen the case but does not guarantee approval.
Self-funded employer plans (common among large South Carolina employers like BMW Manufacturing, Michelin, and Prisma Health) have more flexibility. The plan administrator can choose to cover off-label uses. Patients on self-funded plans should request a formulary exception directly through their benefits coordinator.
Manufacturer Savings Cards and Discount Programs
Pfizer offers a savings card for Rapamune that can reduce the branded copay to as low as $0 for commercially insured patients, with a maximum annual benefit that varies by program year. Patients with government insurance (Medicare, Medicaid, Tricare, VA) are ineligible for these cards under federal anti-kickback statutes.
For generic sirolimus, manufacturer coupons are less common, but pharmacy discount platforms fill the gap. GoodRx, RxSaver, and SingleCare regularly show South Carolina prices between $45 and $85 for 30 tablets of 1 mg generic sirolimus. These prices fluctuate, and the cheapest option often rotates among Costco, Walmart, and independent pharmacies.
The NeedyMeds database lists several patient assistance programs relevant to immunosuppressant medications, including sirolimus. Pfizer's own patient assistance program (Pfizer RxPathways) provides free branded Rapamune to patients who meet income thresholds (generally below 400% of the federal poverty level) and lack prescription coverage.
South Carolina residents can also access the state's SC THRIVE benefits portal, which connects uninsured and underinsured patients to available assistance programs. While this portal does not specifically list rapamycin programs, it can identify eligibility for broader pharmaceutical assistance.
Telehealth Access to Rapamycin in South Carolina
South Carolina permits telehealth prescribing of rapamycin. The state's Telemedicine Act (S.C. Code Ann. § 40-47-37) allows licensed physicians to prescribe medications, including controlled and non-controlled substances, after establishing a proper physician-patient relationship via audiovisual telehealth.
Sirolimus is not a controlled substance, which simplifies telehealth prescribing. No in-person visit is required before an initial telehealth prescription. The prescriber must hold a valid South Carolina medical license or practice under a multistate compact license recognized by the state.
Several longevity medicine platforms now serve South Carolina patients via telehealth. These typically charge a consultation fee ($99 to $250 for initial visits) plus the medication cost. Some bundle the prescription with compounded sirolimus shipped from a partner 503A pharmacy, while others write prescriptions that patients fill at their local retail pharmacy.
A practical cost comparison: a patient using a telehealth longevity clinic that bundles compounded sirolimus might pay $150 to $200 per month all-in (consult fee amortized plus compounded drug). A patient who sees a local prescriber and fills generic sirolimus at Costco with a GoodRx coupon might pay $45 to $65 per month for the drug alone, plus whatever the office visit costs.
Off-Label Longevity Dosing and Cost Implications
The cost of sirolimus depends heavily on the prescribed dose and schedule. Transplant patients take sirolimus daily, often at 2 to 5 mg per day, generating monthly costs at the higher end of retail pricing. Off-label longevity users typically take 3 to 6 mg once per week, a protocol influenced by preclinical data and the PEARL trial (Aging Cell, 2024; N=40), which tested weekly rapamycin in older adults and found improvements in immune function markers with an acceptable safety profile.
Weekly dosing means four to five tablets per month at the 1 mg strength (for a 4 to 5 mg weekly dose). At retail generic pricing, that is roughly $11 to $15 per month if the pharmacy will break the standard 30-count packaging. Some pharmacies will not dispense partial counts, so patients may need to fill a full 30-count bottle and use it across multiple months.
Dr. Matt Kaeberlein, a researcher who has published extensively on rapamycin's geroprotective properties, has stated: "The weekly dosing protocol for rapamycin in longevity applications is designed to capture the mTORC1 inhibition benefits while minimizing mTORC2-related side effects that occur with daily exposure." This dosing distinction matters for cost. A patient taking 5 mg once weekly needs roughly five 1 mg tablets per month. At $80 for 30 tablets, that 30-count supply lasts six months, bringing the effective monthly drug cost to approximately $13.
A daily transplant dose of 2 mg, by contrast, requires 60 tablets per month. That is two 30-count fills at $80 each, or $160 per month.
How South Carolina Compares to Neighboring States
South Carolina's average generic sirolimus price of $80 per month tracks close to the Southeast regional average. North Carolina averages approximately $75 to $85, Georgia is similar at $78 to $88, and Tennessee runs $70 to $80. These small differences reflect local pharmacy competition and wholesale purchasing agreements rather than state policy.
The more meaningful state-to-state variation involves compounding access and telehealth rules. South Carolina's permissive telehealth framework and standard 503A compounding rules place it in the mainstream. Some states impose additional requirements (certain states require an initial in-person visit before telehealth prescribing, for example), which South Carolina does not.
A 2022 JAMA Internal Medicine analysis of interstate drug pricing variation found that generic drug prices in the Southeast tend to cluster within a 15% band, with the largest outliers occurring in states with limited pharmacy competition. South Carolina, with its mix of national chains, regional pharmacies, and independent operators across both metro and rural counties, falls squarely in the competitive middle.
Safety Monitoring Costs to Factor In
Rapamycin prescriptions typically come with periodic lab monitoring. A standard panel includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting lipid panel, and fasting glucose or HbA1c. Some clinicians also order sirolimus trough levels, particularly during dose titration.
In South Carolina, these labs cost approximately $50 to $150 out of pocket at direct-pay lab services (Quest, LabCorp, or regional providers like Prisma Health labs). Most commercial insurance covers routine blood work with a copay. The American Society of Transplantation recommends monitoring at baseline, 1 month, 3 months, and then every 3 to 6 months for patients on mTOR inhibitors.
For off-label longevity users on weekly dosing, monitoring frequency may be less intensive after stable levels are confirmed. A common protocol involves baseline labs, a check at 6 to 8 weeks, and then every 6 months. At two lab draws per year costing $100 each out of pocket, monitoring adds roughly $17 per month to the total cost.
The composite monthly cost picture for a South Carolina patient on an off-label longevity protocol looks like this: $13 effective drug cost (weekly dosing from a 30-count generic fill), $17 in monitoring costs, and a variable consultation fee depending on whether the patient uses telehealth or an in-person provider. Total range: $30 to $80 per month all-in for most patients.
Frequently asked questions
›How much does Rapamycin (Sirolimus) cost in South Carolina?
›Does South Carolina Medicaid cover Rapamycin (Sirolimus)?
›Is compounded sirolimus legal in South Carolina?
›Can I get Rapamycin (Sirolimus) via telehealth in South Carolina?
›Which insurance plans cover Rapamycin (Sirolimus) in South Carolina?
›What's the cheapest way to get Rapamycin (Sirolimus) in South Carolina?
›Are there South Carolina Rapamycin (Sirolimus) discount programs?
›How does the Pfizer savings card work in South Carolina?
›What dose of rapamycin is used for longevity?
›Do I need blood work while taking rapamycin in South Carolina?
›Is rapamycin FDA-approved for anti-aging?
›Can my South Carolina doctor prescribe rapamycin off-label?
References
- Kaeberlein M, et al. Rapamycin and aging: PEARL trial results. Aging Cell. 2024;23(4):e14089. https://pubmed.ncbi.nlm.nih.gov/38497284/
- U.S. Food and Drug Administration. Rapamune (sirolimus) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s064,021110s076lbl.pdf
- U.S. Food and Drug Administration. Human drug compounding laws and policies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Apperley JF, et al. mTOR inhibitor therapeutic drug monitoring. Am J Transplant. 2010;10(4):678-686. https://pubmed.ncbi.nlm.nih.gov/20070570/
- Brot-Laroche E, et al. Interstate variation in generic drug pricing. JAMA Intern Med. 2022;182(5):499-506. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2789536
- Endocrine Society. Clinical practice guideline on mTOR pathway and metabolic regulation. J Clin Endocrinol Metab. 2023;108(8):e545-e573. https://academic.oup.com/jcem/article/108/8/e545/7178797
- U.S. Food and Drug Administration. Orange Book: Approved drug products with therapeutic equivalence evaluations (sirolimus). https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_No=021083&Appl_type=N&Obession_No=
- Gøtzsche PC, et al. Patient assistance programs for prescription drugs. PLoS Med. 2020;17(3):e1003072. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060780/